Soft Tissue Sarcoma
Soft tissue sarcoma is a rare type of cancer that develops in the soft tissues of the body, such as muscles, fat, blood vessels, nerves, and deep skin tissues. It can cause swelling or lumps in the affected area.
We are testing a new vaccine made from patients' own tumor cells for those with resected stage IV neuroendocrine tumors and soft tissue sarcomas. The study aims to evaluate safety and how well the immune system responds to the treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Soft tissue sarcoma is a rare type of cancer that develops in the soft tissues of the body, such as muscles, fat, blood vessels, nerves, and deep skin tissues. It can cause swelling or lumps in the affected area.
Neuroendocrine tumors (NETs) are rare tumors that arise from neuroendocrine cells, which are found throughout the body. They can produce hormones and may cause various symptoms depending on their location and hormone production.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.